Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
Clinical trial NCT03524820 · TERMINATED
Trial details
- NCT number
- NCT03524820
- Sponsor
- Hadassah Medical Organization
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2021-12-31
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.